Trade Summary
2 days ago, Cowan Elvia, serving as SVP, Finance, CAO at Vaxcyte, Inc. (PCVX), sold 3,000 shares at $60.00 per share, for a total transaction value of $180,000.00. Following this transaction, Cowan Elvia now holds 28,975 shares of PCVX.
This sale represents a 9.00% decrease in Cowan Elvia's stake in the company. This is considered a high-conviction trade given the significant change in ownership.
The trade was executed on Tuesday, April 7, 2026 and publicly disclosed via SEC Form 4 filing on Wednesday, April 8, 2026, 1 day after the trade was made.
Vaxcyte, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.